Modular Medical's GLP-1 Personalized Metabolic Therapy Study Utilizing MODD1 Platform
Wednesday, 11 September 2024, 05:14
Overview of the Study
Modular Medical has officially announced the finalization of its protocol for a pivotal GLP-1 personalized metabolic therapy study utilizing the MODD1 platform. This initiative marks a significant step forward in personalized medicine.
Key Details
- Proof of Concept Study: Set to commence in October 2024.
- Data Expected: Results anticipated in November 2024.
- Pre-clinical Study: Focuses on the use of the MODD1 pump as a personalized delivery system for metabolic therapy.
This study embodies a new direction in the treatment of metabolic disorders, with Modular Medical leading the charge.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.